| 
			
			 The U.S. Justice Department sued in July to stop Anthem's purchase 
			of Cigna, a deal that would have created the largest U.S. health 
			insurer by membership, and Aetna Inc's planned $33 billion 
			acquisition of Humana. 
 The merger would have worsened an already highly concentrated market 
			and is likely to raise prices, Judge Amy Berman Jackson of the U.S. 
			District Court for the District of Columbia said while issuing the 
			ruling against Anthem's deal.
 
 Last month, a different U.S. judge ruled against Aetna's proposed 
			deal for Humana.
 
 Government antitrust officials argued that both deals would lead to 
			less competition and higher prices for Americans. The acquisitions 
			would have reduced the number of large national U.S. insurers from 
			five to three.
 
			
			 
			Jackson had separated the Justice Department's case into two trials. 
			Her ruling focused only on the first one in which the Justice 
			Department argued that the tie-up would hurt the ability of large 
			national employers to get competitive rates for the health coverage 
			they provide workers.
 The second trial considered overlaps in the two insurers' business 
			selling health benefits to individuals, and administering Medicare 
			Advantage coverage to the elderly.
 
 Anthem argued that there was enough competition because large 
			companies with more than 5,000 employees often used multiple smaller 
			players in the national market, but the judge disagreed.
 
 "Regional firms and new specialized 'niche' companies that lack a 
			national network are not viable options for the vast majority of 
			national accounts, and they will not ameliorate the anticompetitive 
			effects of this merger," Jackson wrote.
 
 Cigna intends to carefully review the opinion and evaluate its 
			options in accordance with the merger agreement, it said in a 
			statement.
 
 Anthem said on Thursday that it intends to promptly file a notice of 
			appeal and request an expedited hearing of its appeal to reverse the 
			court's decision.
 
 PROTECTING CONSUMERS
 
 Acting Assistant Attorney General Brent Snyder of the Justice 
			Department's Antitrust Division said the ruling had prevented 
			American consumers from facing higher health insurance premiums and 
			less innovation.
 
 Bill Baer, who was head of the Justice Department's antitrust 
			division when it decided to sue to block both the insurance deals 
			but has since left the agency, also hailed the decision. "Together 
			with the decision on Aetna and Humana, this preserves five large 
			national providers of critically important health insurance 
			products," he said.
 
 The fifth player, UnitedHealth Group Inc. was not involved in the 
			deals.
 
 Some Wall Street analysts expect all four of the companies to now 
			move on, although Aetna and Humana have not committed to doing so. 
			Their deal expires Feb. 15.
 
			
            [to top of second column] | 
 
			"The likelihood of success in an appeal would be very low," said 
			Matthew L. Cantor, a partner in the law firm of Constantine Cannon 
			in New York. He noted points in the judge's order about the 
			concentrated national market, the high barrier to entry for 
			competitors, and the companies' roles as direct competitors. 
			The deals were announced at a time when former President Barack 
			Obama's national healthcare reform law was fully in place and the 
			four insurers were growing in the individual insurance market it 
			established. The insurers said new costs, from higher taxes to 
			investments in new Obamacare products, were driving their need for 
			scale.
 That landscape is less certain now. Aetna and Humana have cut back 
			Obamacare enrollment for 2017 after losses, and President Donald 
			Trump and fellow Republicans are weighing a "repeal and replace" 
			path for Obamacare.
 
 More deals may be in the offing, JPMorgan analyst Gary Taylor said 
			in a research note. "Given Anthem and Cigna's pursuit of Humana in 
			2015, we think new potential combinations could emerge." He does not 
			expect shares in either Anthem or Cigna to move given that investors 
			had expected this ruling.
 
			Cigna is entitled to receive from Anthem a $1.85 billion break-up 
			fee if the deal fails to win regulatory approval, according to the 
			merger agreement. The agreement also requires Cigna to have put 
			forth its best effort on that front.
 But Anthem and Cigna disagreed about the deal in court, Jackson 
			wrote in her order, with Cigna refusing to sign off on Anthem's 
			interpretation of how the companies could garner savings.
 
			
			 
			Anthem is the largest member of the Blue Cross Blue Shield 
			Association and operates BCBS plans in 14 states. It and said it 
			could apply its discounts to Cigna members while Cigna said its 
			collaborations with doctors would save money.
 Pre-merger integration was stalled and incomplete, the judge said.
 
 (Additional reporting by Akankshita Mukhopadhyay and Dipika Jain in 
			Bengaluru; Editing by Bernard Orr, Leslie Adler, Gopakumar Warrier)
 
			[© 2017 Thomson Reuters. All rights 
				reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. |